Search Results - robert yu

3 Results Sort By:
Sulfoglucuronosyl paragloboside regulation in inflammation: use of siRNA and/or antisense oligonucleotide as anti-inflammatories
TECH ID 2011-028 Title: Methods and Compositions for Maintaining Blood-Brain Barrier IntegrityCurrent State of the Art: The BBB tightly regulates access to the brain that prevents large molecule therapy transport. Certain infections and disorders would benefit from allowing controlled access of therapeutics across the BBB including but not limited ...
Published: 8/14/2019   |   Inventor(s): Robert Yu, Somsankar Dasgupta
Category(s): Therapeutics
Development of Peptide Mimics of GM1 Ganglioside: A Prophylactic for Cholera
Tech ID: 2012-004 Title: Peptide Mimics for Treatment of GM-1 Associated Diseases Including Cholera and Guillain-Barre SyndromeCurrent State of the Art: Ganglioside GM1-associated diseases or infections are prevalent worldwide, and hundreds of millions of people are infected, or diagnosed, with ganglioside GM1-associated diseases each year. Exempla...
Published: 8/13/2019   |   Inventor(s): Robert Yu, Han-Chung Wu, Seigo Usuki
Category(s): Therapeutics
Development of Novel Therapies for Experimental Guillain-Barre Syndrome Using Ganglioside-Like Phage-Peptide
Current State of the Art: Guillain Barre syndrome is currently treated by administering pain relievers and other palliative forms of care to reduce the symptoms associated with the disease. Guillain Barre currently affects about 1 out of 50,000 people world-wide and in some instances has proven to be fatal due to limited treatments readily avai...
Published: 8/13/2019   |   Inventor(s): Robert Yu, Seigo Usuki
Keywords(s): Guillain-Barre, Phage-Peptide, Therapeutics
Category(s): Therapeutics
© 2019. All Rights Reserved. Powered by Inteum